Beyond Stage IV: Rethinking Oligometastatic Lung Cancer

Episode
377
Soundcloud
Share

In this episode, Dr. Narjust Florez is joined by Dr. Yasir Elamin and Dr. Liliana Faroni to explore the evolving management of oligometastatic lung cancer. They break down key definitions, discuss when and how to use consolidative therapies like radiation and surgery, and examine patient selection, limitations, and emerging tools such as ctDNA that are shaping a more precise approach to care.

Guest
Narjust Florez
Narjust Florez

MD

Associate Director of the Cancer Care Equity Program and Assistant Professor of Medicine
Dana-Farber Cancer Institute
Harvard Medical School
Yasir Elamin
Yasir Elamin

MD

Associate Professor of Thoracic Medical
University of Texas MD Anderson Cancer Center
Liliana Faroni
Liliana Faroni

MD, PhD

Radiation Oncologist
Oncologia D’Or, Rio de Janeiro